Clinical Trial Update: JKB-121 for the Treatment of Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for JKB-121 in nonalcoholic steatohepatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• JKB-121

Snippet

Sponsor: Manal Abdelmalek | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-07